The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Neomile Corporate Advisory Ltd & Neomile Growth ....
AHCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.8 pts more than Nifty Microcap 250 and 4.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Neomile Corporate Advisory Limited along with Neomile Growth Fund-Series 1 has acquired 46,06,839 equity shares of Anlon Healthcare Ltd, representing 8.67% of the company's total share capital. The shares were purchased through open market transactions between 3rd September 2025 and 5th September 2025. Before this acquisition, the acquirer held Nil shares; after the acquisition, it holds 8.67%. The acquirer is not part of the promoter/promoter group of the company. The disclosure was filed under Regulation 29(1), which is triggered when an acquirer's shareholding crosses the 5% threshold in a financial year. The total equity share capital of Anlon Healthcare stands at 5,31,51,500 shares.
A non-promoter institutional investor building an 8.67% stake signals confidence in the company from external money managers. Shareholders should note this new sizable shareholder and watch whether Neomile increases its stake further toward or beyond the 10% open-offer trigger threshold, which could attract more investor attention to the stock.